Interleukin‐11 receptor is an alternative α‐receptor for interleukin‐6 and the chimeric cytokine IC 7
The FEBS Journal · 2025
DOI: 10.1111/febs.17309 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Hendrik T Weitz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany. Hauptthemen laut MEDLINE: Interleukin-6, Receptors, Interleukin-11, Interleukin-11 Receptor alpha Subunit. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The cytokine interleukin 6 (IL‐6) signals via the IL‐6 α‐receptor (IL‐6Rα or IL‐6R) in complex with the gp130 β‐receptor. Cell type restricted expression of the IL‐6R limits the action of IL‐6 mainly to hepatocytes and some immune cells. Here, we show that IL‐6 also binds to the IL‐11 α receptor (IL‐11Rα or IL‐11R) and induces signaling via IL‐11R:gp130 complexes, albeit with a lower affinity compared to IL‐11. Antagonistic antibodies directed against IL‐11R, but not IL‐6R, inhibit IL‐6 signaling via IL‐11R:gp130 receptor complexes. Notably, IL‐11 did not cross‐react with IL‐6R. IL‐11R has also been identified as an alternative α receptor for the CNTF/IL‐6‐derived chimeric cytokine IC7, which has recently been shown to induce weight loss in mice. Accordingly, the effects of therapeutic monoclonal antibodies against IL‐6 or IL‐6R, which both block IL‐6 signaling, may be slightly different. These findings provide new insights into IL‐6 signaling and therefore offer new potential therapeutic intervention options in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry and Molecular Biology II, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany.
- Institute of Clinical Biochemistry, Hannover Medical School, Germany.
- Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Germany.
- Centre of Synthetic Biology, Technical University of Darmstadt, Germany.
ORCID-Profile: Christoph Garbers, Harald Kolmar, Jürgen Scheller
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Weitz, H. T., Ettich, J., Rafii, P., Wittich, C., Schultz, L., Frank, N. C., Heise, D., Krusche, M., Lokau, J., Garbers, C., Behnke, K., Floss, D. M., Kolmar, H., Moll, J. M., & Scheller, J. (2025). Interleukin‐11 receptor is an alternative α‐receptor for interleukin‐6 and the chimeric cytokine IC 7. The FEBS Journal. https://doi.org/10.1111/febs.17309
Vancouver
Weitz HT, Ettich J, Rafii P, Wittich C, Schultz L, Frank NC, et al. Interleukin‐11 receptor is an alternative α‐receptor for interleukin‐6 and the chimeric cytokine IC 7. The FEBS Journal. 2025. doi:10.1111/febs.17309
BibTeX
@article{Weitz2025,
author = {Weitz, Hendrik T and Ettich, Julia and Rafii, Puyan and Wittich, Christoph and Schultz, Laura and Frank, Nils C and Heise, Denise and Krusche, Matthias and Lokau, Juliane and Garbers, Christoph and Behnke, Kristina and Floss, Doreen M and Kolmar, Harald and Moll, Jens M and Scheller, Jürgen},
title = {Interleukin‐11 receptor is an alternative α‐receptor for interleukin‐6 and the chimeric cytokine IC 7},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.17309}
}
EUVIMED